Merck KGaA (OTCMKTS:MKKGY) Sees Significant Decline in Short Interest

Posted by on Jul 13th, 2026

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the recipient of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 97,736 shares, a decline of 66.7% from the June 15th total of 293,910 shares. Based on an average trading volume of 181,804 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.0% of the company’s shares are short sold.

Merck KGaA Stock Performance

Shares of MKKGY stock opened at $32.00 on Monday. The stock has a market capitalization of $20.68 billion, a PE ratio of 14.22, a PEG ratio of 2.81 and a beta of 1.00. The business’s 50 day simple moving average is $30.40 and its 200 day simple moving average is $28.79. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.51 and a quick ratio of 1.00. Merck KGaA has a one year low of $23.73 and a one year high of $34.19.

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.14. Merck KGaA had a net margin of 12.07% and a return on equity of 8.79%. The firm had revenue of $6.03 billion for the quarter, compared to the consensus estimate of $5.93 billion. As a group, research analysts forecast that Merck KGaA will post 1.87 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Sanford C. Bernstein raised shares of Merck KGaA to a “hold” rating in a research note on Thursday, March 19th. HSBC raised shares of Merck KGaA to a “hold” rating in a research note on Monday, July 6th. Finally, Jefferies Financial Group initiated coverage on Merck KGaA in a research report on Tuesday, May 26th. They set a “hold” rating for the company. Six equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.

Read Our Latest Stock Report on Merck KGaA

About Merck KGaA

(Get Free Report)

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.